MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01452nam a22002177a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
ISI Library, Kolkata |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240814145349.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240814b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241206853 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
ISI Library |
| Language of cataloging |
English |
| Transcribing agency |
ISI |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
100 SD:610.621 |
| Item number |
WHO.TR.685 |
| 110 1# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
The use of essential drugs : |
| Remainder of title |
report of a WHO Expert Committee, meeting held in Geneva from 29 November to 3 December 1982/ |
| Statement of responsibility, etc |
World Health Organization |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva : |
| Name of publisher, distributor, etc |
World Health Organization, |
| Date of publication, distribution, etc |
1983 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
46 Pages: |
| Dimensions |
20 cm. |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
World Health Organization technical report series ; no. 685 |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Introduction -- 2. Guidelines for establishing a national programme for essential drugs -- 3. Guidelines for the selection of essential drugs -- 4. Guidelines for the selection of pharmaceutical dosage forms -- 5. Updating of lists of essential drugs -- 6. Provision of information on essential drugs -- 7. Quality assurance -- 8. Research and Development -- 9. Specialized applications of the essential-drugs concept -- 10. Revised model list of essential drugs -- 11. Changes made in revising the model list -- 12. Essential drugs and primary health care -- 13. Glossary of terms used in the report |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
The use of essential drugs |
| Source of heading or term |
Report of a WHO Expert Committee |
| 710 1# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization (WHO) Expert Committee |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Reports |
